ⓘ Lenvervimab

                                     

ⓘ Lenvervimab

Lenvervimab is a monoclonal antibody that is being investigated for hepatitis B.

This drug is being developed by GK Pharma. Starting in 2018, lenvervimab undergoing phase II / III clinical trials.

                                     
  • Tuvirumab Chimeric - vixi - Cosfroviximab Larcaviximab Porgaviximab Humanized - vizu - Felvizumab Lenvervimab Motavizumab Palivizumab Suvizumab
  • granulocyte antigen diagnostic agent Lendalizumab mab humanized C5 Lenvervimab mab humanized hepatitis B surfage antigen hepatitis B Lenzilumab mab